Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections. | Int J Mol Sci | 2023 | 37762059 | PubTator, text mining | PubMed |
| The Structural Abnormalities Are Deeply Involved in the Cause of RPGRIP1-Related Retinal Dystrophy in Japanese Patients. | Int J Mol Sci | 2023 | 37761981 | PubTator, text mining | PubMed |
| GMP-grade human neural progenitors delivered subretinally protect vision in rat model of retinal degeneration and survive in minipigs. | J Transl Med | 2023 | 37743503 | PubTator, text mining | PubMed |
| The State of Intraoperative OCT in Vitreoretinal Surgery: Recent Advances and Future Challenges. | Tomography | 2023 | 37736985 | PubTator, text mining | PubMed |
| Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results. | Stem Cells Transl Med | 2023 | 37713598 | PubTator, text mining | PubMed |
| Insights into vitamin A in bladder cancer, lack of attention to gut microbiota? | Front Immunol | 2023 | 37711628 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37709773 | PubTator, text mining | PubMed |
| THE JEREMIAH METZGER LECTURE: TURNING GENES INTO MEDICINES: HIGHLIGHTS AND HURDLES IN THE DEVELOPMENT OF GENE THERAPY FOR GENETIC DISEASE. | Trans Am Clin Climatol Assoc | 2023 | 37701622 | PubTator, text mining | PubMed |
| Modifying immune responses to adeno-associated virus vectors by capsid engineering. | Mol Ther Methods Clin Dev | 2023 | 37693943 | PubTator, text mining | PubMed |
| Integration of human stem cell-derived in vitro systems and mouse preclinical models identifies complex pathophysiologic mechanisms in retinal dystrophy. | Front Cell Dev Biol | 2023 | 37691820 | PubTator, text mining | PubMed |
| Revisiting Retinal Degeneration Hallmarks: Insights from Molecular Markers and Therapy Perspectives. | Int J Mol Sci | 2023 | 37685886 | PubTator, text mining | PubMed |
| Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec. | Mol Ther Methods Clin Dev | 2023 | 37674905 | PubTator, text mining | PubMed |
| GeNetOntology: identifying affected gene ontology terms via grouping, scoring, and modeling of gene expression data utilizing biological knowledge-based machine learning. | Front Genet | 2023 | 37671046 | PubTator, text mining | PubMed |
| iOCT-guided simulated subretinal injections: a comparison between manual and robot-assisted techniques in an ex-vivo porcine model. | J Robot Surg | 2023 | 37670151 | PubTator, text mining | PubMed |
| Characterising the diagnosis of genetic maculopathies in a real-world private tertiary retinal practice in Australia: protocol for a retrospective clinical audit. | Ann Med | 2023 | 37634060 | PubTator, text mining | PubMed |
| Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology. | Pharmaceuticals (Basel) | 2023 | 37631061 | PubTator, text mining | PubMed |
| Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders. | Pharmaceuticals (Basel) | 2023 | 37631054 | PubTator, text mining | PubMed |
| A Comprehensive Report of Intrinsically Disordered Regions in Inherited Retinal Diseases. | Genes (Basel) | 2023 | 37628652 | PubTator, text mining | PubMed |
| Exogenous CFH Modulates Levels of Pro-Inflammatory Mediators to Prevent Oxidative Damage of Retinal Pigment Epithelial Cells with the At-Risk CFH Y402H Variant. | Antioxidants (Basel) | 2023 | 37627535 | PubTator, text mining | PubMed |
| Soluble CX3CL1-expressing retinal pigment epithelium cells protect rod photoreceptors in a mouse model of retinitis pigmentosa. | Stem Cell Res Ther | 2023 | 37605279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=15